On November 20, 2025, Linde plc issued ?600 million aggregate principal amount of Floating Rate Notes due 2027 (the ?2027 Notes?), issued ?650 million aggregate principal amount of 3.125% Notes due 2032 (the ?2032 Notes?) and issued ?500 million aggregate principal amount of 3.750% Notes due 2038 (the ?2038 Notes?). The 2027 Notes, the 2032 Notes and the 2038 Notes were issued pursuant to a Subscription Agreement, dated November 18, 2025, by and among the Company, as issuer, and the financial institutions named as bookrunners and other managers therein (the ?Managers?). The terms of the 2027 Notes, the 2032 Notes and the 2038 Notes are set out in the Final Terms filed as Exhibit 4.1 which is incorporated herein by reference.
The net proceeds of the offering were approximately ?1,737 million, after giving effect to the fees to the Managers but before other fees and expenses of the offering. Net proceeds of the offering will be used for general corporate purposes. The 2027 Notes, the 2032 Notes and the 2038 Notes have been admitted to the official list of the Luxembourg Stock Exchange and for trading on the Euro MTF market operated by the Luxembourg Stock Exchange.
The 2027 Notes, the 2032 Notes and the 2038 Notes were issued under the European debt issuance programme (the ?Program?) established on May 11, 2020 by the Company, as last updated on May 8, 2025. The current base prospectus dated May 8, 2025, was supplemented by the first supplement on August 21, 2025 and the second supplement on October 31, 2025. Under the Program, the Company may issue unsecured notes (?Notes?) with such terms, including currency, interest rate and maturity, as agreed by the Company and the purchasers of such Notes at the time of sale and as set out in the final terms (?Final Terms?) for the relevant issue of Notes.
The current Program will be valid for a period of one year from May 8, 2025 after which it will require updating prior to any further issuance of Notes. Upon occurrence of any material event concerning the Company, such as the publication of new financial information, the Program must be supplemented prior to any further issuance of Notes. The aggregate principal amount of Notes authorized under the Program to be outstanding from time to time is ?20 billion (or the equivalent in other currencies).
Notes issued by the Company under the Program will be guaranteed by Linde GmbH, a wholly owned subsidiary of the Company organized under the laws of Germany, and Linde Inc., a wholly owned subsidiary of the Company organized under the laws of Delaware (such guarantees of Linde GmbH and Linde Inc. were filed as Exhibits 4.4 and 4.5, respectively, to Linde plc?s Current Report on Form 8-K dated May 26, 2020, Filing No. 001-38730, and confirmations of such guarantees of Linde GmbH and Linde Inc. were filed as Exhibits 4.6 and 4.7 respectively, to Linde plc?s Current Report on Form 8-K dated June 5, 2025, Filing No. 001-38730, in respect of the increased aggregate principal amount of Notes authorized under the Program, and are incorporated herein by reference).
Pursuant to an Amended and Restated Dealer Agreement, dated May 8, 2025, by and among the Company and Citigroup Global Markets Limited, as arranger and dealer, and the other dealers party thereto from time to time (together the ?Dealers?), the Company has appointed the Dealers to subscribe and pay for Notes issued under the Program on the terms set out therein. The Company has appointed Citibank, N.A., London Branch, as fiscal agent and paying agent for Notes issued under the Program pursuant to a Fiscal Agency Agreement, dated May 8, 2025. The Fiscal Agency Agreement and the Dealer Agreement were filed as Exhibits 4.2 and 1.1, respectively, to Linde plc?s Current Report on Form 8-K dated June 5, 2025, Filing No.
001-38730, and are incorporated herein by reference. Notes issued under the Program by the Company will be issued pursuant to Regulation S under the U.S. Securities Act of 1933, as amended (the ?Securities Act?), will not be registered under the Securities Act and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from registration requirements under the Securities Act. This Current Report on Form 8-K shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, including any securities of the Company.
The foregoing description is qualified in its entirety by reference to the exhibits filed herewith.
